Quarterly report [Sections 13 or 15(d)]

Segment Information

v3.26.1
Segment Information
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2026 2025 2026 2025
Total Revenues $ 78,703  $ 101,685  $ 137,521  $ 155,018 
Less:
Employee related expenses 23,430  18,581  44,432  38,119 
Commercial related expenses 7,084  7,273  14,124  12,612 
Outside clinical trial related expenses 7,409  3,232  14,336  7,603 
Cost of product sales 8,525  4,504  13,131  8,913 
Consultants and third-party services 4,225  3,209  8,231  6,618 
Other segment items 4,455  3,783  7,807  7,277 
Interest (income) expense and other, net (10) 1,121  218  2,383 
Provision for income taxes 6,295  369  9,298  434 
Segment income $ 17,290  $ 59,613  $ 25,944  $ 71,059 
There are no reconciling items or adjustments between segment income presented above and net income as presented in our statements of operations. The CODM does not review assets in evaluating the segment performance, accordingly, such information is not presented.
For details of revenues disaggregated by category, see “Note 3 – Revenues.”
Employee related expenses primarily consist of salaries, employee benefits, other employee related expenses and stock-based compensation expense. For additional details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily consist of travel related expenses, business insurance, taxes and licenses, and subscription services.